deltatrials
Completed NCT01928667

Case-Control Study to Identify Risk Factors for Microscopic Colitis

Risk Factors for Microscopic Colitis: A Dutch Case-Control Study

Sponsor: Maastricht University Medical Center

Conditions Collagenous Colitis Lymphocytic Colitis Microscopic Colitis
Interventions Whole saliva sample
Updated 10 times since 2017 Last updated: Jul 18, 2016 Started: Jul 31, 2014 Primary completion: Jun 30, 2016 Completion: Jul 31, 2016

This observational or N/A phase trial investigates Collagenous Colitis and Lymphocytic Colitis and is currently completed. Maastricht University Medical Center leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 5 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Completed

  2. May 2018 — Jun 2018 [monthly]

    Completed

  3. Apr 2018 — May 2018 [monthly]

    Completed

    Phase: NA → None

  4. Aug 2017 — Apr 2018 [monthly]

    Completed NA

  5. Jan 2017 — Aug 2017 [monthly]

    Completed NA

    First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Maastricht University Medical Center
Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Maastricht, Netherlands